Platixa 5mg Tablet

Platixa 5mg Tablet contains the active ingredient Apixaban, which belongs to the class of medications known as anticoagulants or blood thinners. It is used to prevent blood clots in patients with conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE).

Active Ingredient:

• Apixaban: An oral anticoagulant that works by inhibiting Factor Xa, an enzyme involved in the blood clotting process. By blocking Factor Xa, apixaban prevents the formation of blood clots.

Uses:

Platixa 5mg Tablet is primarily prescribed for the following conditions:

• Atrial Fibrillation: To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
• Deep Vein Thrombosis (DVT): To treat and prevent recurrent DVT and pulmonary embolism (PE) following initial therapy.

Mechanism of Action:

Apixaban inhibits the activity of Factor Xa, which plays a central role in the coagulation cascade. By blocking Factor Xa, apixaban prevents the conversion of prothrombin to thrombin and the subsequent formation of fibrin, thereby reducing the risk of blood clot formation.

Administration:

Take Platixa 5mg Tablet orally, with or without food, as directed by your healthcare provider. Follow the prescribed dosage and duration of treatment.

Side Effects:

Common side effects of Platixa 5mg Tablet may include bleeding, bruising, nausea, and anemia. Contact your healthcare provider immediately if you experience any signs of bleeding, such as unusual bleeding from the gums, nosebleeds, or black, tarry stools.

Precautions:

• Inform your healthcare provider about any pre-existing medical conditions, especially bleeding disorders or liver disease.
• Disclose all medications, including prescription and over-the-counter drugs, as well as any herbal supplements, to avoid potential interactions.
• Avoid activities that may increase the risk of bleeding, such as contact sports or heavy lifting, while taking apixaban.

When Not to Use:

Platixa 5mg Tablet may not be suitable for use in individuals with known hypersensitivity or allergy to apixaban or any components of the tablet. It is contraindicated in patients with active bleeding or a history of bleeding disorders.